Hypoglicemic and Hypolipedimic Effects of Ganoderma lucidum in Streptozotocin-Induced Diabetic Rats

Hypoglicemic and Hypolipedimic Effects of Ganoderma lucidum in Streptozotocin-Induced Diabetic Rats

Background:Ganoderma lucidum (Leyss. Ex. Fr) Karst is a basidiomycete mushroom that has been used for many years as a food supplement and medicine. In Brazil, National Health Surveillance Agency (ANVISA) classified Ganoderma lucidum as a nutraceutical product. The objective of the present work was t...

Full description

Bibliographic Details
Main Authors: Erna Elisabeth Bach, Edgar Matias Bach Hi, Ana Maria Cristina Martins, Paloma A. M. Nascimento, Nilsa Sumie Yamashita Wadt
Format: Article
Language:English
Published: MDPI AG 2018-07-01
Series:Medicines
Subjects:
diabetes
ganoderma
beta-glucan
phenols
kynurenine
tryptophan
Online Access:http://www.mdpi.com/2305-6320/5/3/78

Similar Items

Similar Items